Akèy › Maladi atè koronè › Oklahoma
Etid klinik pou Maladi atè koronè nan Oklahoma
7 etid pou Maladi atè koronè ap chèche patisipan nan sit nan Oklahoma.
Vil nan Oklahoma
Tèks ofisyèl etid la (Anglè)
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
- Oklahoma Heart Hillcrest Medical, Tulsa
Ap rekrite
Laj 18 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT07296744Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- South Oklahoma Heart Research, LLC, Oklahoma City
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06909565A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- South Oklahoma Heart Research, LLC, Oklahoma City
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07521007Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
- Oklahoma City VA Medical Center, Oklahoma City
- Oklahoma Heart Institute at Hillcrest Medical Center, Tulsa
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 19, 2026 · NCT02061436MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- University of Oklahoma Health Science Center, Oklahoma City
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2025 · NCT06271590Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
- Oklahoma Heart, Oklahoma City
Ap rekrite
Tout laj · Tout sèks · Mizajou Jul 24, 2025 · NCT04634240MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- Oklahoma University Health (OU Health), Oklahoma City
Ap rekrite
Laj 18 a 110 · Tout sèks · Mizajou Feb 25, 2025 · NCT05908331Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.